RALEIGH, N.C., May 17, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce that for the third consecutive year it was recognized as the Clinical Research Company [...]
We are dedicated to
the future of clinical development
and to every life it saves.
Learn more about why we do what we do, and what we can do for you. Click to read our story.
See the latest interactions from our social media
#OCTEastCoast begins today in King of Prussia PA, stop by and visit PRA at booth #9
Today is #ClinicalTrialsDay. This day commemorates James Lind, a Scottish physician, who conducted the first controlled clinical trial on May 20th 1747 to determine a better treatment for scurvy. Today, #clinicalresearch remains essential in helping to find new treatments. PRA salutes all our employees around the world who do this important work! http://bit.ly/1ODXRRO
Read the latest updates from our PR department
RALEIGH, N.C., May 02, 2016 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ:PRAH) today announced that certain of its stockholders (the “Selling Stockholders”), intend to [...]
$372.3 million of service revenue in the first quarter; 13.0% constant currency growth compared to the first quarter of 2015 First quarter GAAP Net Loss of $16.0 million or $0.27 per diluted share, [...]
Explore the latest resources uploaded to our media library
Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter
PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.
PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...
A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.
Find out what's happening next on PRA's event schedule
This must-attend event gathers hepatologists from The Czech Republic to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field.
Opioids are effective tools when used properly in the management of pain. They are cost effective and allow increased numbers of patients to return to active productive lives in society. Yet, while opioids have been with us for over 4000 years, the landscape of opioid therapies is rapidly evolving. Federal and state regulations are swiftly […]
DIA 2016 is the largest global interdisciplinary event that brings together key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations from around the globe – and across all disciplines involved in the discovery, development, and life cycle management of health care products. The goal of the DIA […]